Susan Raber Selected Research

Susan Raber Research Topics

3	Intraabdominal Infections 01/2022 - 01/2019
3	Glaucoma 05/2015 - 10/2011
2	Infections 01/2022 - 01/2019
2	Invasive Candidiasis 01/2020 - 01/2020
2	Ocular Hypertension (Glaucoma, Suspect) 10/2011 - 09/2011
1	Syphilis 05/2024
1	Gram-Negative Bacterial Infections 01/2024
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Ventilator-Associated Pneumonia 01/2022
1	Soft Tissue Infections 01/2021
1	Candidemia 01/2020
1	Pneumonia (Pneumonitis) 06/2019
1	Bacterial Pneumonia 01/2019
1	Hyperemia 05/2015
1	Rheumatoid Arthritis 04/2015
1	Body Weight (Weight, Body) 10/2011
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2011

4	Latanoprost (Xalatan)FDA Link 05/2015 - 09/2011
2	avibactamIBA 01/2024 - 01/2020
2	Aztreonam FDA LinkGeneric 01/2024 - 01/2020
2	Ceftaroline FDA Link 01/2021 - 06/2019
2	Anidulafungin FDA Link 01/2020 - 01/2020
1	SuspensionsIBA 05/2024
1	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 05/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	ceftazidime drug combination avibactamIBA 01/2022
1	LactamsIBA 01/2022
1	Monobactams (Monobactam Antibiotics)IBA 01/2020
1	Fluconazole (Zonal)FDA LinkGeneric 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2019
1	Levofloxacin (Levaquin)FDA Link 06/2019
1	Tigecycline (Tygacil)FDA Link 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 05/2015
1	ProstaglandinsIBA 05/2015
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 05/2015
1	tofacitinibIBA 04/2015
1	Janus Kinase InhibitorsIBA 04/2015
1	AcidsIBA 10/2011

4	Therapeutics 05/2024 - 03/2013